Search EdNeuro Page
Search EdNeuro Page
The search found 60 results in 0.032 seconds.
The pioneering dementia ‘buddy scheme’ headed by Dr Chris Henstridge (Centre for Discovery Brain Sciences) and co-ordinated by Lilian Kennedy (Social Anthropology) was recently featured on BBC News. The scheme pairs university researchers with people who are living with dementia to enable them to learn from each other.
Prof Tara Spires-Jones (Centre for Discovery Brain Sciences) and colleagues have published a study investigating Alzheimer's, showing that a protein called clusterin builds up in vital parts of neurons, synapses, and may damage these links.
Professor Tara Spires-Jones (Centre for Discovery Brain Sciences) has co-led a study that has demonstrated the presence of phosphorylated α-synuclein at synapses, and disrupted synaptic function, in brain tissue from patients with a common form of dementia, Dementia with Lewy Bodies.
A dementia ward at the Royal Edinburgh Hospital has been given a makeover as part of a project funded by a University of Edinburgh Innovation Initiative Grant that explores how colour can improve the daily experience of patients, visitors and staff. This collaboration between Edinburgh College of Art and ArtLink, staff at the Royal Edinburgh Hospital, and patients' relatives has helped to create a calmer environment according to hospital staff.
Congratulations to Dr Barry McColl (Centre for Discovery Brain Sciences) and his research group, who are part of an international consortium, Stroke-ImPACT which was recently awarded €6M from Fondation Leducq to study the immunological mechanisms linking stroke and dementia.
Congratulations to Dr Tom MacGillivray, Prof Craig Ritchie, Prof Bal Dhillon and Dr Graciela Muniz Terrera, in the Centre for Clinical Brain Sciences, for being among the first group of researchers to receive funding from the Alzheimer's Drug Discovery Foundation through its Diagnostics Accelerator.
Dr Will Whiteley (Stroke Research Group, Centre for Clinical Brain Sciences) has been awarded a prestigious Scottish Senior Clinical Fellowship from the Chief Scientist Office to study the contribution of vascular risk factors to dementia.
Professor Brian Walker, Professor Jonathan Seckl and Dr. Scott Webster (all Centre for Cardiovascular Sciences) have developed a drug, Xanamem, that has just entered Phase II clinical trials and been administered to the first patient by Actinogen Medical in Australia.
The University of Edinburgh is joining with five other institutions to form the UK Dementia Research Intitute (UK DRI), along with charity partners Alzheimer's Society and Alzheimer's Research UK.